1-2 of 2
Alex Miller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study

Free
Mark C. Walters, Alexis A. Thompson, Janet L. Kwiatkowski, Suhag Parikh, Markus Y. Mapara, Stacey Rifkin-Zenenberg, Banu Aygun, Kimberly A. Kasow, Alex Miller, Lixin Zhang, Anjulika Chawla, Elizabeth R. Macari, Francis J. Pierciey, Jr., John F. Tisdale, Julie Kanter
Journal: Blood
Blood (2022) 140 (Supplement 1): 26–28.
https://doi.org/10.1182/blood-2022-162288
Published: 2022
Journal Articles

Polyclonality Strongly Correlates with Biological Outcomes and Is Significantly Increased Following Improvements to the Phase 1/2 HGB-206 Protocol and Manufacturing of LentiGlobin for Sickle Cell Disease (SCD; bb1111) Gene Therapy (GT)

Free
John F. Tisdale, Alexis A. Thompson, Markus Y. Mapara, Janet L. Kwiatkowski, Lakshmanan Krishnamurti, Banu Aygun, Kimberly A. Kasow, Stacey Rifkin-Zenenberg, Manfred Schmidt, Francis J. Pierciey, Jr., Dustin Whitney, Cynthia Rogers, Mauris Nnamani, Marianna Foos, Alex Miller, Xinyan Zhang, Jessie Lynch, Mark C. Walters, Julie Kanter, Melissa Bonner
Journal: Blood
Blood (2021) 138 (Supplement 1): 561.
https://doi.org/10.1182/blood-2021-147760
Published: 2021